Form 8-K - Current report:
SEC Accession No. 0001104659-26-071001
Filing Date
2026-06-05
Accepted
2026-06-05 16:30:37
Documents
11
Period of Report
2026-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2617045d1_8k.htm   iXBRL 8-K 29066
  Complete submission text file 0001104659-26-071001.txt   194388

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20260605.xsd EX-101.SCH 3023
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20260605_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20260605_pre.xml EX-101.PRE 22364
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2617045d1_8k_htm.xml XML 3205
Mailing Address 3090 NOWITZKI WAY SUITE 300 DALLAS TX 75219
Business Address 3090 NOWITZKI WAY SUITE 300 DALLAS TX 75219 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 261069607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)